Concurrent Use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors with Palliative Radiotherapy for Metastatic Breast Cancer Patients: A Review of Toxicity

Özlem SÖNMEZ; Evrim TEZCANLI

doi:10.5505/tjo.2021.3338

Current Issue

Forthcoming Issue

Archive

Supplements

Türkçe

The Official Journal of Turkish Society for Radiation Oncology

TURKISH JOURNAL OF ONCOLOGY 2021 , Vol 36 , Num 4

Abstract Full Text PDF Similar Articles Mail to Author

Concurrent Use of Cyclin Dependent Kinase 4/6 (CDK4/6) Inhibitors with Palliative Radiotherapy for Metastatic Breast Cancer Patients: A Review of Toxicity

Özlem SÖNMEZ¹,Evrim TEZCANLI²

¹Department of Medical Oncology, Acıbadem Mehmet Ali Aydınlar University, Istanbul-Turkey
²Department of Radiation Oncology, Acıbadem Altunizade Hospital, Istanbul-Turkey DOI : 10.5505/tjo.2021.3338 Keywords :

Home

Informations For Authors

Retractions

Contact